UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Donor‐Transmitted Malignancies in Organ Transplantation: Assessment of Clinical Risk

American journal of transplantation, 2011-06, Vol.11 (6), p.1140-1147

2011

Volltextzugriff (PDF)

PHASE 2 STUDY OF IBRUTINIB WITH TEMOZOLOMIDE, ETOPOSIDE, LIPOSOMAL DOXORUBICIN, DEXAMETHASONE, RITUXIMAB (TEDDI‐R) FOR SECONDARY CNS LYMPHOMA

Hematological oncology, 2023-06, Vol.41 (S2), p.44-46

2023

Volltextzugriff (PDF)

Overview of posttransplant B-cell lymphoproliferative disorders

Seminars in oncology, 1999-10, Vol.26 (5), p.21-25

SWINNEN, L. J

1999

Volltextzugriff (PDF)

Pharmacokinetically-targeted dosed everolimus maintenance therapy in lymphoma patients

Cancer chemotherapy and pharmacology, 2018-02, Vol.81 (2), p.347-354

2018

Volltextzugriff (PDF)

Methylation Status of the Epstein-Barr Virus Major Latent Promoter C in Iatrogenic B Cell Lymphoproliferative Disease : Application of PCR-Based Analysis

The American journal of pathology, 1999-08, Vol.155 (2), p.619-625

1999

Volltextzugriff (PDF)

Transplantation-related lymphoproliferative disorder: a model for human immunodeficiency virus-related lymphomas

Seminars in oncology, 2000-08, Vol.27 (4), p.402-408

Swinnen, L J

2000

Volltextzugriff (PDF)

TREATMENT OF ORGAN TRANSPLANT–RELATED LYMPHOMA

Hematology/oncology clinics of North America, 1997-10, Vol.11 (5), p.963-973

Swinnen, Lode J.

1997

Volltextzugriff (PDF)

CpG Methylation of the Major Epstein-Barr Virus Latency Promoter in Burkitt's Lymphoma and Hodgkin's Disease

Blood, 1996-10, Vol.88 (8), p.3129-3136

1996

Volltextzugriff (PDF)

Simian Virus 40 Is Present in Most United States Human Mesotheliomas, but It Is Rarely Present in Non-Hodgkin's Lymphoma

Chest, 1999-12, Vol.116 (6), p.470S-473S

1999

Volltextzugriff (PDF)

BCL-2 But Not Its Epstein-Barr Virus-Encoded Homologue, BHRF1, Is Commonly Expressed in Posttransplantation Lymphoproliferative Disorders

Blood, 1996-01, Vol.87 (2), p.706-711

1996

Volltextzugriff (PDF)

Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy

Transplantation, 2003-09, Vol.76 (6), p.959

2003

Volltextzugriff (PDF)

Post-transplant lymphoproliferative disorders: implications for acquired immunodeficiency syndrome-associated malignancies

Journal of the National Cancer Institute. Monographs, 2001 (28), p.38-43

Swinnen, L J

2001

Volltextzugriff (PDF)

Geographically Distinct HHV-8 DNA Sequences in Saudi Arabian Iatrogenic Kaposi's Sarcoma Lesions

The American journal of pathology, 1998-09, Vol.153 (3), p.1001-1004

1998

Volltextzugriff (PDF)

Organ transplant-related lymphoma

Current treatment options in oncology, 2001-08, Vol.2 (4), p.301-308

Swinnen, L J

2001

Volltextzugriff (PDF)

Interim positron emission tomography in limited-stage diffuse large B cell lymphoma: A modern will-o'-the-wisp?

The National medical journal of India, 2021-01, Vol.34 (1), p.37-39

2021

Volltextzugriff (PDF)

Epstein-Barr virus (EBV) variant with a 30-bp deletion at the carboxyl terminus (amino acids 346-355) of latent membrane protein-1 (LMP1) gene is able to transform cells and evade immune surveillance

The American journal of pathology, 1998-05, Vol.152 (5), p.1398-1399

1998

Volltextzugriff (PDF)

Comparative analysis of the expression of the epstein-barr virus (EBV) anti-apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV-related lymphoid diseases

Journal of medical virology, 2001-09, Vol.65 (1), p.105-113

2001

Volltextzugriff (PDF)

Frequent expression of the tumor necrosis factor receptor–associated factor 1 in latent membrane protein 1–Positive posttransplant lymphoproliferative disease and HIV-associated lymphomas

Human pathology, 2001-09, Vol.32 (9), p.963-969

2001

Volltextzugriff (PDF)

Multicenter phase II study of rituximab-ABVD in classic Hodgkin lymphoma (cHL)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.8039-8039

2011

Volltextzugriff (PDF)

OKT3 monoclonal antibodies induce interleukin-6 and interleukin-10: a possible cause of lymphoproliferative disorders associated with transplantation

Current opinion in nephrology and hypertension, 1993-07, Vol.2 (4), p.670-678

1993

Volltextzugriff (PDF)

Analytic validation of a competitive polymerase chain reaction assay for measuring Epstein-Barr viral load

Diagnostic molecular pathology, 2001-12, Vol.10 (4), p.255-264

2001

Volltextzugriff (PDF)

Transplant immunosuppression-related malignant lymphomas

Cancer treatment and research, 1993, Vol.66, p.95

Swinnen, L J

1993

Volltextzugriff (PDF)

Phase II study of hydroxyurea for unresectable meningioma (Southwest Oncology Group S9811)

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.2063-2063

2009

Volltextzugriff (PDF)

VENETOCLAX (VEN), BENDAMUSTINE (B) AND RITUXIMAB (R) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) NON‐HODGKIN LYMPHOMA (NHL): FINAL RESULTS OF a PHASE I STUDY

Hematological oncology, 2017-06, Vol.35 (S2), p.90-90

2017

Volltextzugriff (PDF)

Phase I trial of yttrium 90 ibritumomab tiuxetan ( 90 Y-RIT) with autologous stem cell transplantation (ASCT) in patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma (NHL)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.8565-8565

2008

Volltextzugriff (PDF)

1 – 25 von 213

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)
Mit Volltextzugriff
(168)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(178)
Französisch
(37)

Erscheinungsjahr

n.n

Thema

Science & Technology
(77)
Life Sciences & Biomedicine
(69)
Humans
(44)
Biological And Medical Sciences
(36)
Medical Sciences
(25)
Europe
(15)
Neurosciences & Neurology
(13)
Oncology
(13)
Animals
(12)
Fundamental And Applied Biological Sciences. Psychology
(12)
Transplantation
(12)
Neurosciences
(11)
Adult
(9)
Epstein-Barr Virus
(8)
Hematologic And Hematopoietic Diseases
(8)
Hematology
(8)
Immunology
(8)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(8)
Molecular Sequence Data
(8)
Paléolithique Et Mésolithique
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Donor‐Transmitted Malignancies in Organ Transplantation: Assessment of Clinical Risk

PHASE 2 STUDY OF IBRUTINIB WITH TEMOZOLOMIDE, ETOPOSIDE, LIPOSOMAL DOXORUBICIN, DEXAMETHASONE, RITUXIMAB (TEDDI‐R) FOR SECONDARY CNS LYMPHOMA

Overview of posttransplant B-cell lymphoproliferative disorders

Pharmacokinetically-targeted dosed everolimus maintenance therapy in lymphoma patients

Methylation Status of the Epstein-Barr Virus Major Latent Promoter C in Iatrogenic B Cell Lymphoproliferative Disease : Application of PCR-Based Analysis

Transplantation-related lymphoproliferative disorder: a model for human immunodeficiency virus-related lymphomas

TREATMENT OF ORGAN TRANSPLANT–RELATED LYMPHOMA

CpG Methylation of the Major Epstein-Barr Virus Latency Promoter in Burkitt's Lymphoma and Hodgkin's Disease

Simian Virus 40 Is Present in Most United States Human Mesotheliomas, but It Is Rarely Present in Non-Hodgkin's Lymphoma

BCL-2 But Not Its Epstein-Barr Virus-Encoded Homologue, BHRF1, Is Commonly Expressed in Posttransplantation Lymphoproliferative Disorders

Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy

Post-transplant lymphoproliferative disorders: implications for acquired immunodeficiency syndrome-associated malignancies

Geographically Distinct HHV-8 DNA Sequences in Saudi Arabian Iatrogenic Kaposi's Sarcoma Lesions

Organ transplant-related lymphoma

Interim positron emission tomography in limited-stage diffuse large B cell lymphoma: A modern will-o'-the-wisp?

Epstein-Barr virus (EBV) variant with a 30-bp deletion at the carboxyl terminus (amino acids 346-355) of latent membrane protein-1 (LMP1) gene is able to transform cells and evade immune surveillance

Comparative analysis of the expression of the epstein-barr virus (EBV) anti-apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV-related lymphoid diseases

Frequent expression of the tumor necrosis factor receptor–associated factor 1 in latent membrane protein 1–Positive posttransplant lymphoproliferative disease and HIV-associated lymphomas

Multicenter phase II study of rituximab-ABVD in classic Hodgkin lymphoma (cHL)

OKT3 monoclonal antibodies induce interleukin-6 and interleukin-10: a possible cause of lymphoproliferative disorders associated with transplantation

Analytic validation of a competitive polymerase chain reaction assay for measuring Epstein-Barr viral load

Transplant immunosuppression-related malignant lymphomas

Phase II study of hydroxyurea for unresectable meningioma (Southwest Oncology Group S9811)

VENETOCLAX (VEN), BENDAMUSTINE (B) AND RITUXIMAB (R) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) NON‐HODGKIN LYMPHOMA (NHL): FINAL RESULTS OF a PHASE I STUDY

Phase I trial of yttrium 90 ibritumomab tiuxetan ( 90 Y-RIT) with autologous stem cell transplantation (ASCT) in patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma (NHL)

Aktive Filter

Suchergebnisse filtern